喵ID:UeMuxr免责声明

Treatment with targeted vesicular stomatitis virus generates therapeutic multifunctional anti-tumor memory CD4 T cells.

基本信息

DOI:
10.1038/cgt.2011.90
发表时间:
2012-04
影响因子:
6.4
通讯作者:
中科院分区:
医学3区
文献类型:
Journal Article
作者: 研究方向: -- MeSH主题词: --
关键词: --
来源链接:pubmed详情页地址

文献摘要

A generally applicable, easy-to-use method of focusing a patient's immune system to eradicate or prevent cancer has been elusive. We are attempting to develop a targeted virus to accomplish these aims. We previously created a recombinant replicating Vesicular Stomatitis Virus that preferentially infected Her2/neu expressing breast cancer cells and showed therapeutic efficacy in an implanted Balb/c mouse tumor model. The current work shows that this therapy generated therapeutic anti-tumor CD4 T-cells against multiple tumor antigens. CD4 T-cells transferred directly from cured donor mice could eradicate established tumors in host mice. T-cells were transferred directly from donor mice and were not stimulated ex vivo. Both tumors that expressed Her2/neu and those that did not were cured by transferred T-cells. Analysis of cytokines secreted by anti-tumor memory CD4 T-cells displayed a multifunctional pattern with high levels of IFNγ, IL-4 and IL-17. Anti-tumor memory CD4 T-cells traveled to the mesenteric lymph nodes and were activated there. Treatment with targeted rrVSV is a potent immune adjuvant that generates therapeutic, multifunctional anti-tumor memory CD4 T-cells that recognize multiple tumor antigens. Immunity elicited by viral therapy is independent of host major histocompatibility complex (MHC) or knowledge of tumor antigens. Virus-induced tumor immunity could have great benefit in the prevention and treatment of tumor metastases.
一种普遍适用且易于使用的、能使患者免疫系统聚焦于根除或预防癌症的方法一直难以找到。我们正试图开发一种靶向病毒来实现这些目标。我们先前创造了一种重组复制型水疱性口炎病毒,它优先感染表达Her2/neu的乳腺癌细胞,并在植入的Balb/c小鼠肿瘤模型中显示出治疗效果。目前的研究表明,这种疗法产生了针对多种肿瘤抗原的治疗性抗肿瘤CD4 T细胞。直接从治愈的供体小鼠转移的CD4 T细胞能够根除宿主小鼠体内已形成的肿瘤。T细胞是直接从供体小鼠转移的,没有在体外进行刺激。表达Her2/neu的肿瘤和不表达的肿瘤都能被转移的T细胞治愈。对抗肿瘤记忆CD4 T细胞分泌的细胞因子的分析显示出一种多功能模式,具有高水平的干扰素γ、白细胞介素 - 4和白细胞介素 - 17。抗肿瘤记忆CD4 T细胞迁移到肠系膜淋巴结并在那里被激活。靶向重组水疱性口炎病毒(rrVSV)治疗是一种有效的免疫佐剂,它能产生具有治疗作用的、多功能的抗肿瘤记忆CD4 T细胞,这些细胞能识别多种肿瘤抗原。病毒疗法引发的免疫不依赖于宿主主要组织相容性复合体(MHC)或对肿瘤抗原的了解。病毒诱导的肿瘤免疫在肿瘤转移的预防和治疗中可能具有很大益处。
参考文献(0)
被引文献(0)
RECOMBINANT VESICULAR STOMATITIS VIRUSES FROM DNA
DOI:
10.1073/pnas.92.10.4477
发表时间:
1995-05-09
期刊:
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
影响因子:
11.1
作者:
LAWSON, ND;STILLMAN, EA;ROSE, JK
通讯作者:
ROSE, JK
Treatment of metastatic melanoma with autologous CD4+T cells against NY-ESO-1
DOI:
10.1056/nejmoa0800251
发表时间:
2008-06-19
期刊:
NEW ENGLAND JOURNAL OF MEDICINE
影响因子:
158.5
作者:
Hunder, Naomi N.;Wallen, Herschel;Yee, Cassian
通讯作者:
Yee, Cassian
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells
DOI:
10.1073/pnas.0503726102
发表时间:
2005-07-05
期刊:
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
影响因子:
11.1
作者:
Klebanoff, CA;Gattinoni, L;Restifo, NP
通讯作者:
Restifo, NP
Treatment of implanted mammary tumors with recombinant vesicular stomatitis virus targeted to Her2/neu
DOI:
10.1002/ijc.22680
发表时间:
2007-07-15
期刊:
INTERNATIONAL JOURNAL OF CANCER
影响因子:
6.4
作者:
Bergman, Ira;Griffin, Judith A.;Whitaker-Dowling, Patricia
通讯作者:
Whitaker-Dowling, Patricia
Therapeutic effect of idiotype-specific CD4+ T cells against B-cell lymphoma in the absence of anti-idiotypic antibodies
DOI:
10.1182/blood-2002-11-3381
发表时间:
2003-07-15
期刊:
BLOOD
影响因子:
20.3
作者:
Lundin, KU;Hofgaard, PO;Bogen, B
通讯作者:
Bogen, B

数据更新时间:{{ references.updateTime }}

关联基金

Targeted Recombinant VSV Virus to Treat Breast Cancer
批准号:
7416754
批准年份:
2005
资助金额:
26.87
项目类别:
通讯地址:
--
所属机构:
--
电子邮件地址:
--
免责声明免责声明
1、猫眼课题宝专注于为科研工作者提供省时、高效的文献资源检索和预览服务;
2、网站中的文献信息均来自公开、合规、透明的互联网文献查询网站,可以通过页面中的“来源链接”跳转数据网站。
3、在猫眼课题宝点击“求助全文”按钮,发布文献应助需求时求助者需要支付50喵币作为应助成功后的答谢给应助者,发送到用助者账户中。若文献求助失败支付的50喵币将退还至求助者账户中。所支付的喵币仅作为答谢,而不是作为文献的“购买”费用,平台也不从中收取任何费用,
4、特别提醒用户通过求助获得的文献原文仅用户个人学习使用,不得用于商业用途,否则一切风险由用户本人承担;
5、本平台尊重知识产权,如果权利所有者认为平台内容侵犯了其合法权益,可以通过本平台提供的版权投诉渠道提出投诉。一经核实,我们将立即采取措施删除/下架/断链等措施。
我已知晓